|
Volumn 35, Issue 6, 2002, Pages 247-248
|
Acute psychosis after administration of bupropion hydrochloride (Zyban™)
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
CANNABIS;
NICOTINE;
ACUTE DISEASE;
ADULT;
ALCOHOL CONSUMPTION;
ARTICLE;
BIOCHEMISTRY;
CASE REPORT;
CAUCASIAN;
CIGARETTE SMOKING;
CLINICAL FEATURE;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONCENTRATION (PARAMETERS);
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE CALCULATION;
DRUG MECHANISM;
DRUG OVERDOSE;
DRUG SAFETY;
DRUG TOLERANCE;
ELECTROENCEPHALOGRAM;
HALLUCINATION;
HUMAN;
INSOMNIA;
LUMBAR PUNCTURE;
LUNG CARCINOMA;
NEUROLOGIC EXAMINATION;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
PSYCHOSIS;
SLEEP DISORDER;
SMOKING CESSATION;
SUICIDAL BEHAVIOR;
SUSTAINED RELEASE PREPARATION;
VISUAL IMPAIRMENT;
WITHDRAWAL SYNDROME;
XEROSTOMIA;
ADULT;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
ANTIPSYCHOTIC AGENTS;
BUPROPION;
HALLUCINATIONS;
HUMANS;
MALE;
PSYCHOSES, SUBSTANCE-INDUCED;
SMOKING CESSATION;
SULPIRIDE;
|
EID: 0036869974
PISSN: 01763679
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2002-36393 Document Type: Article |
Times cited : (28)
|
References (7)
|